David Hwang

Mr. Hwang currently is Senior Director of Strategy and Corporate Development at Agilent Technologies and a Managing Director of Agilent’s Early Stage Partnership Program that helps early stage companies navigate the complex life science ecosystem. He has more than 18 years of experience in corporate development, venture investment, corporate financing, and M&A.

Mr. Hwang is responsible for managing strategic investments, partnerships, and mergers and acquisitions (M&A) globally. He has worked on several transformational initiatives including the spinoff of Keysight Technologies from Agilent in 2014 and Agilent’s $2.2 billion acquisition of Dako, a Danish cancer diagnostics company. Prior to joining Agilent, Mr. Hwang held several senior roles at boutique investment banks in New York City and San Francisco. He holds a BA from Brandeis University and an MBA from Rutgers University.